BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34846916)

  • 1. Global Risk Indicator and Therapy for Older Patients With Diffuse Large B-Cell Lymphoma: A Population-Based Study.
    Di M; Keeney T; Belanger E; Panagiotou OA; Olszewski AJ
    JCO Oncol Pract; 2022 Mar; 18(3):e383-e402. PubMed ID: 34846916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional status and therapy for older adults with diffuse large B-cell lymphoma in nursing homes: A population-based study.
    Di M; Keeney T; Belanger E; Huntington SF; Olszewski AJ; Panagiotou OA
    J Am Geriatr Soc; 2023 Jul; 71(7):2239-2249. PubMed ID: 36882865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncologist volume and outcomes in older adults diagnosed with diffuse large B cell lymphoma.
    Huntington SF; Hoag JR; Zhu W; Wang R; Zeidan AM; Giri S; Podoltsev NA; Gore SD; Ma X; Gross CP; Davidoff AJ
    Cancer; 2018 Nov; 124(21):4211-4220. PubMed ID: 30216436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Preexisting Heart Failure With Outcomes in Older Patients With Diffuse Large B-Cell Lymphoma.
    Upshaw JN; Nelson J; Rodday AM; Kumar AJ; Klein AK; Konstam MA; Wong JB; Jaffe IZ; Ky B; Friedberg JW; Maurer M; Kent DM; Parsons SK
    JAMA Cardiol; 2023 May; 8(5):453-461. PubMed ID: 36988926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment patterns and comparative effectiveness in elderly diffuse large B-cell lymphoma patients: a surveillance, epidemiology, and end results-medicare analysis.
    Hamlin PA; Satram-Hoang S; Reyes C; Hoang KQ; Guduru SR; Skettino S
    Oncologist; 2014 Dec; 19(12):1249-57. PubMed ID: 25342313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and Predictors of Palliative Care Utilization among Hospitalized Patients with Diffuse Large B-Cell Lymphoma.
    Jackson I; Etuk A; Jackson N
    J Palliat Care; 2023 Apr; 38(2):167-174. PubMed ID: 35006019
    [No Abstract]   [Full Text] [Related]  

  • 7. Survival of older patients with cancer in the Veterans Health Administration versus fee-for-service Medicare.
    Landrum MB; Keating NL; Lamont EB; Bozeman SR; Krasnow SH; Shulman L; Brown JR; Earle CC; Rabin M; McNeil BJ
    J Clin Oncol; 2012 Apr; 30(10):1072-9. PubMed ID: 22393093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burden of illness and outcomes in second-line large B-cell lymphoma treatment: real-world analysis of Medicare beneficiaries.
    Kilgore KM; Mohammadi I; Wong AC; Snider JT; Cheng P; Schroeder A; Patel AR
    Future Oncol; 2021 Dec; 17(35):4837-4847. PubMed ID: 34645318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous-thromboembolism and associated health care utilization in elderly patients with diffuse large B cell lymphoma.
    Gangaraju R; Davis ES; Bhatia S; Kenzik KM
    Cancer; 2022 Jun; 128(12):2348-2357. PubMed ID: 35363373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediation analyses of socioeconomic factors determining racial differences in the treatment of diffuse large B-cell lymphoma in a cohort of older adults.
    Guadamuz JS; Ozenberger K; Qato DM; Ko NY; Saffore CD; Adimadhyam S; Cha AS; Moran KM; Sweiss K; Patel PR; Chiu BC; Calip GS
    Medicine (Baltimore); 2019 Nov; 98(46):e17960. PubMed ID: 31725657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease characteristics, patterns of care, and survival in very elderly patients with diffuse large B-cell lymphoma.
    Williams JN; Rai A; Lipscomb J; Koff JL; Nastoupil LJ; Flowers CR
    Cancer; 2015 Jun; 121(11):1800-8. PubMed ID: 25675909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin, cardiac risk factors, and cardiac toxicity in elderly patients with diffuse B-cell non-Hodgkin's lymphoma.
    Hershman DL; McBride RB; Eisenberger A; Tsai WY; Grann VR; Jacobson JS
    J Clin Oncol; 2008 Jul; 26(19):3159-65. PubMed ID: 18591554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL).
    Griffiths R; Gleeson M; Knopf K; Danese M
    BMC Cancer; 2010 Nov; 10():625. PubMed ID: 21073707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors for Early Death After Rituximab-Based Immunochemotherapy in Older Patients With Diffuse Large B-Cell Lymphoma.
    Olszewski AJ; Mantripragada KC; Castillo JJ
    J Natl Compr Canc Netw; 2016 Sep; 14(9):1121-9. PubMed ID: 27587624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A population-based multistate model for diffuse large B-cell lymphoma-specific mortality in older patients.
    Çağlayan Ç; Goldstein JS; Ayer T; Rai A; Flowers CR
    Cancer; 2019 Jun; 125(11):1837-1847. PubMed ID: 30707765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mental health disorders and survival among older patients with diffuse large B-cell lymphoma in the USA: a population-based study.
    Kuczmarski TM; Tramontano AC; Mozessohn L; LaCasce AS; Roemer L; Abel GA; Odejide OO
    Lancet Haematol; 2023 Jul; 10(7):e530-e538. PubMed ID: 37271158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second-line therapy in diffuse large B-cell lymphoma (DLBCL): treatment patterns and outcomes in older patients receiving outpatient chemotherapy.
    Danese MD; Griffiths RI; Gleeson ML; Dalvi T; Li J; Mikhael JR; Deeter R; Dreyling M
    Leuk Lymphoma; 2017 May; 58(5):1094-1104. PubMed ID: 27659997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes after intensive care unit admission in newly diagnosed diffuse large B-cell lymphoma patients: A real-life study.
    Zduniak A; Mihailescu SD; Lequesne J; Lenain P; Contentin N; Pepin LF; Ménard AL; Leprêtre S; Lemasle E; Lanic H; Stamatoullas-Bastard A; Tilly H; Tamion F; Jardin F; Camus V
    Eur J Haematol; 2021 Jun; 106(6):788-799. PubMed ID: 33624346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment Patterns and Survival in Older Adults with Diffuse Large B-cell Lymphoma: A Population-Based Study.
    Maguire FB; Li Q; Morris CR; Parikh-Patel A; Rosenberg AS; Keegan THM
    J Registry Manag; 2020; 47(3):135-145. PubMed ID: 34128920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.